DK0508220T3 - Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf - Google Patents

Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf

Info

Publication number
DK0508220T3
DK0508220T3 DK92105138.9T DK92105138T DK0508220T3 DK 0508220 T3 DK0508220 T3 DK 0508220T3 DK 92105138 T DK92105138 T DK 92105138T DK 0508220 T3 DK0508220 T3 DK 0508220T3
Authority
DK
Denmark
Prior art keywords
preparation
contents
processes
amidinophenylalanine derivatives
amidinophenylalanine
Prior art date
Application number
DK92105138.9T
Other languages
Danish (da)
English (en)
Inventor
Werner Stueber
Gerhard Dickneite
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of DK0508220T3 publication Critical patent/DK0508220T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
DK92105138.9T 1991-04-09 1992-03-25 Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf DK0508220T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4111394A DE4111394A1 (de) 1991-04-09 1991-04-09 Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel

Publications (1)

Publication Number Publication Date
DK0508220T3 true DK0508220T3 (da) 1995-11-27

Family

ID=6429103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92105138.9T DK0508220T3 (da) 1991-04-09 1992-03-25 Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf

Country Status (28)

Country Link
US (1) US5274098A (cs)
EP (1) EP0508220B1 (cs)
JP (1) JPH0597793A (cs)
KR (1) KR920019738A (cs)
CN (1) CN1067431A (cs)
AT (1) ATE125549T1 (cs)
AU (1) AU650526B2 (cs)
BG (1) BG60683B1 (cs)
BR (1) BR9201253A (cs)
CA (1) CA2065585A1 (cs)
CS (1) CS106492A3 (cs)
DE (2) DE4111394A1 (cs)
DK (1) DK0508220T3 (cs)
ES (1) ES2076595T3 (cs)
FI (1) FI921525A7 (cs)
GR (1) GR3017107T3 (cs)
HU (1) HUT65359A (cs)
IE (1) IE67347B1 (cs)
IL (1) IL101529A (cs)
MA (1) MA22495A1 (cs)
MX (1) MX9201642A (cs)
NO (1) NO921382L (cs)
NZ (1) NZ242246A (cs)
PL (1) PL294148A1 (cs)
RO (1) RO109197B1 (cs)
TW (1) TW214542B (cs)
UY (1) UY23395A1 (cs)
ZA (1) ZA922535B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4242655A1 (de) * 1992-12-17 1994-06-23 Behringwerke Ag Verwendung von Thrombin-Inhibitoren zur Inhibition okularer Fibrinbildung
DE4342154A1 (de) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
AU3107795A (en) * 1994-08-09 1996-03-07 Pentapharm Ag Inhibitors of the benzamidine type
US5525617A (en) * 1994-08-24 1996-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
DE19517198C1 (de) * 1995-05-11 1996-10-10 Samson Ag Verfahren zur Führung der Hubstellung eines Stellgliedes
US5766932A (en) * 1995-12-20 1998-06-16 Hoechst Marion Roussel, Inc. Process for preparing N-acetyl(L)-4-cyanophenylalanine from a mixture of the corresponding D,L ethyl esters using subtilisin
EP0868526B1 (en) * 1995-12-20 2002-08-14 Aventis Pharmaceuticals Inc. PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-BETA-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH2
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
KR19990074598A (ko) * 1998-03-12 1999-10-05 성재갑 고체상 반응을 이용한 벤즈아미딘 유도체의 신규한 제조방법
AU7874001A (en) 2000-08-18 2002-03-04 Ajinomoto Kk Novel phenylalanine derivatives
SI21137A (sl) * 2002-01-24 2003-08-31 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Derivati azafenilalanina
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
CN103784458B (zh) 2003-12-22 2015-10-14 味之素株式会社 苯基丙氨酸衍生物
US7994221B2 (en) 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
CA2590962A1 (en) 2004-12-06 2006-06-15 Siga Technologies, Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US8410149B2 (en) 2004-12-06 2013-04-02 Siga Technologies Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
CN101034257B (zh) * 2007-04-06 2010-09-08 上海复旦天臣新技术有限公司 用于全息记录的感光薄膜及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028380A (en) * 1974-06-01 1977-06-07 Akzona Incorporated Hydrazino-imidazole derivatives
DD155954B1 (de) * 1981-02-03 1988-11-09 Wagner Guenter Verfahren zur herstellung von n tief alpha arly-bzw. n tief alpha heteroarylsulfonylaminoacylierten amidinophenylalaninamiden
DD235866B1 (de) * 1985-03-29 1988-12-28 Univ Leipzig Verfahren zur herstellung von n alpha (2-naphthyl)-sulfonylaminoacylierten amidinophenylalanisamiden
PT84171B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados das n alfa-aril-sulfonilamiminoacil-p- -amidinofenil-alaninamidas, bem como dos seus derivados de sintese e das composicoes farmaceuticas que os contem
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas

Also Published As

Publication number Publication date
KR920019738A (ko) 1992-11-19
CN1067431A (zh) 1992-12-30
US5274098A (en) 1993-12-28
NO921382L (no) 1992-10-12
ZA922535B (en) 1992-11-25
CA2065585A1 (en) 1992-10-10
EP0508220B1 (de) 1995-07-26
GR3017107T3 (en) 1995-11-30
BG60683B1 (bg) 1995-12-29
IE921123A1 (en) 1992-10-21
DE59203006D1 (de) 1995-08-31
MX9201642A (es) 1992-10-01
DE4111394A1 (de) 1992-10-15
IE67347B1 (en) 1996-03-20
HU9201189D0 (en) 1992-07-28
UY23395A1 (es) 1992-04-21
FI921525L (fi) 1992-10-10
IL101529A (en) 1996-05-14
AU1470392A (en) 1992-10-15
TW214542B (cs) 1993-10-11
RO109197B1 (ro) 1994-12-30
AU650526B2 (en) 1994-06-23
FI921525A0 (fi) 1992-04-07
FI921525A7 (fi) 1992-10-10
CS106492A3 (en) 1992-10-14
IL101529A0 (en) 1992-12-30
BG96171A (bg) 1993-12-24
NO921382D0 (no) 1992-04-08
HUT65359A (en) 1994-05-02
ES2076595T3 (es) 1995-11-01
ATE125549T1 (de) 1995-08-15
JPH0597793A (ja) 1993-04-20
EP0508220A1 (de) 1992-10-14
PL294148A1 (cs) 1993-02-08
MA22495A1 (fr) 1992-12-31
BR9201253A (pt) 1992-12-01
NZ242246A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
DK0508220T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstiling, deres anvendelse og midler med in dhold deraf
DK573384D0 (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
FI942913A7 (fi) Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisäl tävät farmaseuttiset koostumukset
NO924027D0 (no) Heterobiarylderivater, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
NO922940D0 (no) Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem
DK157592D0 (da) Dualinhibitorer for no synthese og cyclooxygenase, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse
NO932120D0 (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
DK1117661T3 (da) Propanolaminderivater substitueret med heterocycliske grupper, fremgangsmåde til deres fremstilling, farmaceutiske præparater indeholdende disse forbindelser og deres anvendelse
DK162491D0 (da) Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
DK250387D0 (da) Di- og tetrahydroisoquinolin-derivater, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK102990D0 (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK383388D0 (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
DK304090A (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK154382A (da) Hidtil ukendte derivater af 2-piperazinopyrimidin,fremgangsmaader til deres fremstilling og deres anvendelse som laegemidlereller mellemprodukter til fremstilling af laegemidler
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK395788A (da) Oploeselige silybinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
NO922358D0 (no) Tert.-butylfenyl-1-amino-4-hydroksybutanderivater, fremgangsmaate ved deres fremstilling og farmasoeytiske preparaterinneholdende forbindelsene
NO933558D0 (no) Benzimidazoler, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling
DK155692A (da) Benzofuranylimidazolderivater, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse
DK630088D0 (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
DK673787A (da) Renininhibitorer (iv), fremgangsmaade til deres fremstilling, og farmaceutiske praeparater med indhold af saadanne forbindelser
NO924563D0 (no) Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser
DK159685C (da) Imidazothienopyrimidiner, farmaceutiske praeparater indeholdende disse, en anvendelse af forbindelserne og fremgangsmaade til deres fremstilling
DK159434C (da) Quinoxalinforbindelser, fremgangsmaade til deres fremstilling, en anvendelse af forbindelserne og farmaceutiske praeparater hvori forbindelserne indgaar